Newspaper publication of Notice of loss of share certificate of the Company, published in Financial Express English and Gujarati Editions, both on July 10, 2025.

pdf

Ipca Laboratories Ltd.

10 Jul 2025

1456.80

0.50%

Company Update

Ipca Laboratories Ltd - 524494 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

The Company has enclosed herewith Certificate received from RTA of the Company for the quarter ended 30.06.2025.

pdf

Abbott India Ltd.

10 Jul 2025

34295.00

-0.36%

Company Update

Abbott India Ltd - 500488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025.

pdf

Lupin Ltd.

10 Jul 2025

1926.10

1.66%

Company Update

Lupin Ltd - 500257 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Reg. 74(5) of SEBI (Depositories and Participant) Regulations, 2018, for the quarter ended on June 30, 2025.

pdf

Lupin Ltd.

10 Jul 2025

1926.10

1.66%

Lupin, Zentiva Group ink agreement to commercialise biosimilar Certolizumab Pegol

Business Line

Both parties will invest in the development of the new biosimilar

Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.

Laurus Labs Ltd.

09 Jul 2025

823.85

4.26%

Company Update

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please see annexed enclosure.

pdf

Laurus Labs Ltd.

09 Jul 2025

823.85

4.26%

Board Meeting

Laurus Labs Ltd - 540222 - Board Meeting Intimation for Approval Of Unaudited Financial Results For …

BSE India

Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 ,inter alia, to consider and approve Please see annexed enclosure.

pdf